UA94579C2 - Анетолдитиолтион и другие дитиолтионы для лечения состояний, связанных с дисфункцией нейротрансмисии моноамина - Google Patents
Анетолдитиолтион и другие дитиолтионы для лечения состояний, связанных с дисфункцией нейротрансмисии моноаминаInfo
- Publication number
- UA94579C2 UA94579C2 UAA200710593A UAA200710593A UA94579C2 UA 94579 C2 UA94579 C2 UA 94579C2 UA A200710593 A UAA200710593 A UA A200710593A UA A200710593 A UAA200710593 A UA A200710593A UA 94579 C2 UA94579 C2 UA 94579C2
- Authority
- UA
- Ukraine
- Prior art keywords
- dithiolethiones
- dysfunction
- treatment
- conditions associated
- compounds
- Prior art date
Links
- 230000004064 dysfunction Effects 0.000 title abstract 2
- 230000005062 synaptic transmission Effects 0.000 title abstract 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 title 2
- LZENMJMJWQSSNJ-UHFFFAOYSA-N 3H-1,2-dithiole-3-thione Chemical compound S=C1C=CSS1 LZENMJMJWQSSNJ-UHFFFAOYSA-N 0.000 title 1
- 229940011037 anethole Drugs 0.000 title 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 102000010909 Monoamine Oxidase Human genes 0.000 abstract 1
- 108010062431 Monoamine oxidase Proteins 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05101405 | 2005-02-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA94579C2 true UA94579C2 (ru) | 2011-05-25 |
Family
ID=34938805
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200710593A UA94579C2 (ru) | 2005-02-24 | 2006-02-17 | Анетолдитиолтион и другие дитиолтионы для лечения состояний, связанных с дисфункцией нейротрансмисии моноамина |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1858875A2 (ar) |
| JP (1) | JP2008531519A (ar) |
| KR (1) | KR20070117607A (ar) |
| CN (1) | CN101107240B (ar) |
| AR (1) | AR055862A1 (ar) |
| AU (1) | AU2006218012A1 (ar) |
| BR (1) | BRPI0609043A2 (ar) |
| CA (1) | CA2594165A1 (ar) |
| MX (1) | MX2007010380A (ar) |
| RU (1) | RU2402543C2 (ar) |
| SA (1) | SA06270023B1 (ar) |
| TW (1) | TW200640898A (ar) |
| UA (1) | UA94579C2 (ar) |
| WO (1) | WO2006089861A2 (ar) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0704718D0 (en) * | 2007-03-12 | 2007-04-18 | Prendergast Patrick T | Compounds and methods for preventing and treating mucositis |
| CN102807557B (zh) * | 2012-08-21 | 2015-02-04 | 苏州大学 | 3h-1,2-二硫环戊烯-3-硫酮类化合物及其应用 |
| KR101438415B1 (ko) * | 2013-07-25 | 2014-09-17 | 동국대학교 경주캠퍼스 산학협력단 | 기억력 손상의 예방 또는 개선을 위한 조구등 추출물 |
| CN104788440B (zh) * | 2015-04-03 | 2017-12-26 | 苏州大学 | 烟酸衍生物及其应用 |
| FR3063640B1 (fr) * | 2017-03-07 | 2020-10-09 | Elodie Petitjean | Traitement de la fibrose pulmonaire a l'aide d'un inhibiteur selectif de la production d'especes reactives de l'oxygene d'origine mitochondriale |
| CA3055122A1 (en) | 2017-03-07 | 2018-09-13 | OP2 Drugs | Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ros) production |
| WO2020058767A1 (en) * | 2018-09-18 | 2020-03-26 | St Ip Holding Ag | Rotomeric isomers of 4-alkyl-5-heteroaryl-3h-1,2- dithiole-3-thiones |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1442450A (fr) * | 1964-05-05 | 1966-06-17 | Monsanto Chemicals | Nouveaux composés hétérocycliques contenant du soufre |
| JPH089611B2 (ja) * | 1988-06-20 | 1996-01-31 | 三井東圧化学株式会社 | 新規１，２−ジチオール−３−チオン誘導体およびそれを有効成分とする免疫調節剤 |
| AU5474198A (en) * | 1996-12-24 | 1998-07-17 | National Research Council Of Canada | Treatment of diseases or prevention of cellular damage caused by oxygen-containing free radicals |
| AU6462500A (en) * | 1999-07-29 | 2001-02-19 | Patrick T. Prendergast | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement |
-
2006
- 2006-02-16 TW TW095105223A patent/TW200640898A/zh unknown
- 2006-02-17 JP JP2007556592A patent/JP2008531519A/ja not_active Withdrawn
- 2006-02-17 MX MX2007010380A patent/MX2007010380A/es unknown
- 2006-02-17 KR KR1020077021935A patent/KR20070117607A/ko not_active Ceased
- 2006-02-17 EP EP06708351A patent/EP1858875A2/en not_active Withdrawn
- 2006-02-17 BR BRPI0609043-5A patent/BRPI0609043A2/pt not_active IP Right Cessation
- 2006-02-17 UA UAA200710593A patent/UA94579C2/ru unknown
- 2006-02-17 AU AU2006218012A patent/AU2006218012A1/en not_active Abandoned
- 2006-02-17 WO PCT/EP2006/060060 patent/WO2006089861A2/en not_active Ceased
- 2006-02-17 CN CN2006800030655A patent/CN101107240B/zh not_active Expired - Fee Related
- 2006-02-17 RU RU2007135184/04A patent/RU2402543C2/ru not_active IP Right Cessation
- 2006-02-17 CA CA002594165A patent/CA2594165A1/en not_active Abandoned
- 2006-02-21 SA SA06270023A patent/SA06270023B1/ar unknown
- 2006-02-21 AR ARP060100616A patent/AR055862A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101107240A (zh) | 2008-01-16 |
| MX2007010380A (es) | 2007-09-25 |
| BRPI0609043A2 (pt) | 2010-11-16 |
| AU2006218012A1 (en) | 2006-08-31 |
| RU2007135184A (ru) | 2009-03-27 |
| AR055862A1 (es) | 2007-09-12 |
| JP2008531519A (ja) | 2008-08-14 |
| WO2006089861A3 (en) | 2006-10-26 |
| SA06270023A (ar) | 2005-12-03 |
| CN101107240B (zh) | 2011-02-09 |
| CA2594165A1 (en) | 2006-08-31 |
| KR20070117607A (ko) | 2007-12-12 |
| EP1858875A2 (en) | 2007-11-28 |
| RU2402543C2 (ru) | 2010-10-27 |
| SA06270023B1 (ar) | 2010-10-12 |
| TW200640898A (en) | 2006-12-01 |
| WO2006089861A2 (en) | 2006-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2010005958A3 (en) | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase | |
| MX2010002258A (es) | Compuestos terapeuticos de isoxazol. | |
| TW200726753A (en) | 2,4-diamino-pyrimidines as aurora inhibitors | |
| WO2010093849A3 (en) | Phenylalanine amide derivatives useful for treating insulin-related diseases and conditions | |
| WO2007140385A3 (en) | Thiazole compounds as cannabinoid receptor ligands and uses thereof | |
| EA201001585A1 (ru) | Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк) | |
| WO2008036642A3 (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
| WO2008036653A3 (en) | N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase | |
| SG165315A1 (en) | Alpha2c adrenoreceptor agonists | |
| WO2008030744A3 (en) | Inhibitors of c-met and uses thereof | |
| MX2009000657A (es) | Composiciones y metodos para el tratamiento de mucositis. | |
| MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
| WO2007140439A3 (en) | Compounds as cannabinoid receptor ligands and uses thereof | |
| WO2006048330A8 (en) | 11βετα-hsd1 inhibitors | |
| EP2639229A3 (en) | Thiazole Derivative and use thereof as VAP-1 Inhibitor | |
| MX2010005649A (es) | Compuestos novedosos como ligandos del receptor canabinoide y sus usos. | |
| WO2005005389A3 (en) | Malonamide derivatives | |
| ATE519373T1 (de) | Teezusammensetzung und herstellungsverfahren dafür | |
| WO2007056159A3 (en) | Hydrazone derivatives and uses thereof | |
| MY157116A (en) | Novel seh inhibitors and their use | |
| WO2007126900A3 (en) | Antifungal agents | |
| UA94579C2 (ru) | Анетолдитиолтион и другие дитиолтионы для лечения состояний, связанных с дисфункцией нейротрансмисии моноамина | |
| WO2007017728A3 (en) | Novel heterocyclic compounds | |
| WO2008102888A1 (ja) | 新規擬似糖脂質及びその用途 | |
| SI1745010T1 (sl) | Substituirani cikloheksil-1,4-diaminski derivati |